在老年人群中对小细胞肺癌的文献分析分析
Dyuthi Nallavolu1, Sydney N Vaughn2, Latha Ganti3,4,5
1Research, Orlando Science School, Orlando, USA.
Cureus
|May 22, 2025
概括
对老年人小细胞肺癌 (SCLC) 的研究表明,全球趋势是增加治疗和治疗研究. 美国,中国和日本领导出版物,专注于改善老年患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 老年病的医生 老年病的医生
- 图书统计学 图书统计学
背景情况:
- 小细胞肺癌 (SCLC) 不成比例地影响老年人群.
- 了解研究环境对于推进老年SCLC治疗至关重要.
研究的目的:
- 从1979年到2023年对老年人群进行全球SCLC研究的文献分析.
- 确定关键趋势,领先的国家和研究重点领域在老年人SCLC.
主要方法:
- 数据来源于科学网络核心数据收集.
- 关键词包括"小细胞肺癌"",SCLC"",老年患者"和"65岁以上".
- VOSviewer用于对组织,国家和关键词进行文献计量分析和可视化.
主要成果:
- 分析了1979年至2023年间发表的7710多篇文章.
- 美国,中华人民共和国和日本是最多产的出版国家.
- 关键词表明强烈关注老年患者中SCLC的治疗和治疗.
结论:
- 在老年患者中对SCLC的全球研究越来越专注于开发新疗法和治疗方法.
- 领先国家的持续研究努力可能会带来重大进展和对SCLC的潜在治疗,特别是在老年人群中.
- 这一趋势凸显了对解决老年人致命肺癌诊断的日益承诺.
更多相关视频
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
996
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.5K
相关概念视频
Cancer Survival Analysis
315
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
315
Statistical Methods for Analyzing Epidemiological Data
275
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
275
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
